a phase ii trial has been conducted to determine the effect upon survival of cytoreductive surgery ( nephrectomy ) and adjuvant active immunotherapy ( bacillus calmette-guerin ) in patients with stage iv renal cancer .
C0027695
nephrectomy
C0022646
renal